Skip to main content

Funded Grants

Filter by:
Clear Filters
Filter by:
Lawrence Korngut × Clear Filters

3 results found

Expanding CNDR as an Open Science, Multi-modal Data Platform

Neuromuscular diseases (NMDs) are rare conditions that affect nerves and muscles.

Project ongoing See Project & Researchers
Grant type
Platform grants
Area of Research
Multiple
Competition
2024 Platform Support Grants
Province
Alberta
Start Date
2025

Novel MRI biomarkers for monitoring disease progression in ALS

For this project Dr. Sanjay Kalra and his team aims to improve on current techniques to use magnetic resonance imaging (MRI) as a readily available way to examine if a potential new treatment is working to slow down progression of ALS.

Project ongoing See Project & Researchers
Grant type
Team grants
Area of Research
Neurodegeneration
Competition
ALS Arthur J. Hudson Translational Team Grant
Province
Alberta
Start Date
2016

A Randomized Controlled Trial of Pimozide in Subjects with ALS

This project is a Phase II study involving 100 participants across 8 ALS clinics across Canada. The trial, led by the Principal Investigator of the Canadian Neuromuscular Disease Registry (CNDR) and the Chair of the Canadian ALS Research Network (CALS) will examine whether pimozide, a drug already approved by Health Canada for use in psychoses like schizophrenia and Tourette’s syndrome, might slow progression of ALS.

Project ongoing See Project & Researchers
Grant type
Team grants
Area of Research
Neurodegeneration
Competition
ALS Arthur J. Hudson Translational Team Grant
Province
Alberta
Start Date
2016